PT  - JOURNAL ARTICLE
AU  - Tsetsos, Fotis
AU  - Yu, Dongmei
AU  - Sul, Jae Hoon
AU  - Huang, Alden Y.
AU  - Illmann, Cornelia
AU  - Osiecki, Lisa
AU  - Darrow, Sabrina M.
AU  - Hirschtritt, Matthew E.
AU  - Greenberg, Erica
AU  - Muller-Vahl, Kirsten R.
AU  - Stuhrmann, Manfred
AU  - Dion, Yves
AU  - Rouleau, Guy A.
AU  - Aschauer, Harald
AU  - Stamenkovic, Mara
AU  - Schlögelhofer, Monika
AU  - Sandor, Paul
AU  - Barr, Cathy L.
AU  - Grados, Marco A.
AU  - Singer, Harvey S.
AU  - Nöthen, Markus M.
AU  - Hebebrand, Johannes
AU  - Hinney, Anke
AU  - King, Robert A.
AU  - Fernandez, Thomas V.
AU  - Barta, Csaba
AU  - Tarnok, Zsanett
AU  - Nagy, Peter
AU  - Depienne, Christel
AU  - Worbe, Yulia
AU  - Hartmann, Andreas
AU  - Budman, Cathy L.
AU  - Rizzo, Renata
AU  - Lyon, Gholson J.
AU  - McMahon, William M.
AU  - Batterson, James R.
AU  - Cath, Danielle C.
AU  - Malaty, Irene A.
AU  - Okun, Michael S.
AU  - Berlin, Cheston
AU  - Woods, Douglas W.
AU  - Lee, Paul C.
AU  - Jankovic, Joseph
AU  - Robertson, Mary M.
AU  - Gilbert, Donald L.
AU  - Brown, Lawrence W.
AU  - Coffey, Barbara J.
AU  - Dietrich, Andrea
AU  - Hoekstra, Pieter J.
AU  - Kuperman, Samuel
AU  - Zinner, Samuel H.
AU  - Wagner, Michael
AU  - Knowles, James A
AU  - Willsey, A. Jeremy
AU  - Tischfield, Jay A.
AU  - Heiman, Gary A.
AU  - Cox, Nancy J.
AU  - Freimer, Nelson B.
AU  - Neale, Benjamin M.
AU  - Davis, Lea K.
AU  - Coppola, Giovanni
AU  - Mathews, Carol A.
AU  - Scharf, Jeremiah M.
AU  - Paschou, Peristera
AU - on behalf of the Tourette Association of America International Consortium for Genetics, the Gilles de la Tourette GWAS Replication Initiative, the Tourette International Collaborative Genetics
TI  - Synaptic processes and immune-related pathways implicated in Tourette Syndrome
AID  - 10.1101/2020.04.24.20047845
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.24.20047845
4099  - http://medrxiv.org/content/early/2020/04/27/2020.04.24.20047845.short
4100  - http://medrxiv.org/content/early/2020/04/27/2020.04.24.20047845.full
AB  - Tourette Syndrome (TS) is a neuropsychiatric disorder of complex genetic architecture involving multiple interacting genes. Here, we sought to elucidate the pathways that underlie the neurobiology of the disorder through genome-wide analysis. We analyzed genome-wide genotypic data of 3581 individuals with Tourette Syndrome (TS) and 7682 ancestry-matched controls and investigated associations of TS with sets of genes that are expressed in particular cell types and operate in specific neuronal and glial functions. We employed a self-contained, set-based association method (SBA) as well as a competitive gene set method (MAGMA) using individual-level genotype data to perform a comprehensive investigation of the biological background of TS. Our SBA analysis identified three significant gene sets after Bonferroni correction, implicating Ligand-gated Ion Channel Signaling, Lymphocytic, and Cell Adhesion and Trans-synaptic Signaling processes. MAGMA analysis further supported the involvement of the Cell Adhesion and Trans-synaptic Signaling gene set. The Lympho-cytic gene set was driven by variants in FLT3, raising an intriguing hypothesis for the involvement of a neuroinflammatory element in TS pathogenesis. The indications of involvement of Ligand-gated Ion Channel Signaling reinforce the role of GABA in TS, while the association of Cell Adhesion and Trans-synaptic Signaling gene set provides additional support for the role of adhesion molecules in neuropsychiatric disorders.Competing Interest StatementIM has participated in research funded by the Parkinson Foundation, Tourette Association, Dystonia Coalition, AbbVie, Biogen, Boston Scientific, Eli Lilly, Impax, Neuroderm, Prilenia, Revance, Teva but has no owner interest in any pharmaceutical company. She has received travel compensation or honoraria from the Tourette Association of America, Parkinson Foundation, International Association of Parkinsonism and Related Disorders, Medscape, and Cleveland Clinic, and royalties for writing a book with Robert rose publishers. KMV has received financial or material research support from the EU (FP7-HEALTH-2011 No. 278367, FP7-PEOPLE-2012-ITN No. 316978), the German Research Foundation (DFG: GZ MU 1527/3-1), the German Ministry of Education and Research (BMBF: 01KG1421), the National Institute of Mental Health (NIMH), the Tourette Gesellschaft Deutschland e.V., the Else-Kroner-Fresenius-Stiftung, and GW, Almirall, Abide Therapeutics, and Therapix Biosiences and has received consultant's honoraria from Abide Therapeutics, Tilray, Resalo Vertrieb GmbH, and Wayland Group, speaker’s fees from Tilray and Cogitando GmbH, and royalties from Medizinisch Wissenschaftliche Verlagsgesellschaft Berlin, Elsevier, and Kohlhammer; and is a consultant for Nuvelution TS Pharma Inc., Zynerba Pharmaceuticals, Resalo Vertrieb GmbH, CannaXan GmbH, Therapix Biosiences, Syqe, Nomovo Pharma, and Columbia Care. Benjamin M. Neale is a member of the scientific advisory board at Deep Genomics and consultant for Camp4 Therapeutics, Takeda Pharmaceutical and Biogen. MMN has received fees for memberships in Scientific Advisory Boards from the Lundbeck Foundation and the Robert-Bosch-Stiftung, and for membership in the Medical-Scientific Editorial Office of the Deutsches Ärzteblatt. MMN was reimbursed travel expenses for a conference participation by Shire Deutschland GmbH. MMN receives salary payments from Life & Brain GmbH and holds shares in Life & Brain GmbH. All this concerned activities outside the submitted work. MSO serves as a consultant for the Parkinson’s Foundation, and has received research grants from NIH, Parkinson’s Foundation, the Michael J. Fox Foundation, the Parkinson Alliance, Smallwood Foundation, the Bachmann-Strauss Foundation, the Tourette Syndrome Association, and the UF Foundation. MSO’s DBS research is supported by: NIH R01 NR014852 and R01NS096008. MSO is PI of the NIH R25NS108939 Training Grant. MSO has received royalties for publications with Demos, Manson, Amazon, Smashwords, Books4Patients, Perseus, Robert Rose, Oxford and Cambridge (movement disorders books). MSO is an associate editor for New England Journal of Medicine Journal Watch Neurology. MSO has participated in CME and educational activities on movement disorders sponsored by the Academy for Healthcare Learning, PeerView, Prime, QuantiaMD, WebMD/Medscape, Medicus, MedNet, Einstein, MedNet, Henry Stewart, American Academy of Neurology, Movement Disorders Society and by Vanderbilt University. The institution and not MSO receives grants from Medtronic, Abbvie, Boston Scientific, Abbott and Allergan and the PI has no financial interest in these grants. MSO has participated as a site PI and/or co-I for several NIH, foundation, and industry sponsored trials over the years but has not received honoraria. Research projects at the University of Florida receive device and drug donations. DW receives royalties for books on Tourette Syndrome with Guilford Press, Oxford University Press, and Springer Press.Funding StatementFT was co-financed by Greece and the European Union (European Social Fund- ESF) through the Operational Programme «Human Resources Development, Education and Lifelong Learning» in the context of the project «Reinforcement of Postdoctoral Researchers - 2nd Cycle« (MIS-5033021), implemented by the State Scholarships Foundation (IKY). LKD was supported by grants from the National Institutes of Health including U54MD010722-04, R01NS102371, R01MH113362, U01HG009086, R01MH118223, DP2HD98859, R01DC16977, R01NS105746, R56MH120736, R21HG010652, and RM1HG009034.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData available through the Psychiatric Genomics Consortium. https://www.med.unc.edu/pgc/download-results/